<DOC>
	<DOC>NCT02752737</DOC>
	<brief_summary>Cryo AF Global Registry a prospective, global, multi-center, observational Post-Market Registry</brief_summary>
	<brief_title>Cryo AF Global Registry</brief_title>
	<detailed_description>The Cryo AF Global Registry is a prospective, global, multi-center, observational post-market registry (PMR). The purpose of this study is to evaluate and describe clinical performance and safety data in a broad patient population treated with a commercially available Arctic Front™ Family of Cardiac Cryoablation Catheters (hereafter referred to as "Arctic Front™ Cardiac Cryoablation Catheter System"). The cryoballoon ablation(CBA) procedure will be performed according to routine hospital practice. The study is expected to have a 24 month enrollment period. The follow up period is intended to align with standard practice and subjects will be followed for a minimum of 12 months post-procedure.</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Subject is ≥ 18 years of age or minimum age as required by local regulations Planned procedure using commercially available Arctic Front™ Cardiac Cryoablation Catheter Willing to comply with study requirements and give informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this clinical study) or authorization per institution and geographical requirements Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager Subject with exclusion criteria required by local law</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>